Literature DB >> 30517607

Comparing pulmonary hypertension severity between rat strains suggests right ventricle NK cells are protective.

Claudia Mickael, Michael H Lee, Sue Gu, Brian B Graham.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30517607      PMCID： PMC6657381          DOI： 10.1093/cvr/cvy299

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  13 in total

1.  Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells.

Authors:  Seiichiro Sakao; Laimute Taraseviciene-Stewart; Jong Deog Lee; Kathy Wood; Carlyne D Cool; Norbert F Voelkel
Journal:  FASEB J       Date:  2005-05-16       Impact factor: 5.191

2.  Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure.

Authors:  Harm J Bogaard; Ramesh Natarajan; Scott C Henderson; Carlin S Long; Donatas Kraskauskas; Lisa Smithson; Ramzi Ockaili; Joe M McCord; Norbert F Voelkel
Journal:  Circulation       Date:  2009-11-02       Impact factor: 29.690

3.  Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension.

Authors:  L Taraseviciene-Stewart; Y Kasahara; L Alger; P Hirth; G Mc Mahon ; J Waltenberger; N F Voelkel; R M Tuder
Journal:  FASEB J       Date:  2001-02       Impact factor: 5.191

4.  Marked Strain-Specific Differences in the SU5416 Rat Model of Severe Pulmonary Arterial Hypertension.

Authors:  Baohua Jiang; Yupu Deng; Colin Suen; Mohamad Taha; Ketul R Chaudhary; David W Courtman; Duncan J Stewart
Journal:  Am J Respir Cell Mol Biol       Date:  2016-04       Impact factor: 6.914

5.  Inhibition of VEGF receptors causes lung cell apoptosis and emphysema.

Authors:  Y Kasahara; R M Tuder; L Taraseviciene-Stewart; T D Le Cras; S Abman; P K Hirth; J Waltenberger; N F Voelkel
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

Review 6.  Animal models of pulmonary arterial hypertension: A systematic review and meta-analysis of data from 6126 animals.

Authors:  Katarzyna Sztuka; Magdalena Jasińska-Stroschein
Journal:  Pharmacol Res       Date:  2017-09-01       Impact factor: 7.658

7.  Strain differences in the response of Fischer 344 and Sprague-Dawley rats to monocrotaline induced pulmonary vascular disease.

Authors:  L C Pan; D W Wilson; H J Segall
Journal:  Toxicology       Date:  1993-03-30       Impact factor: 4.221

8.  Temporal hemodynamic and histological progression in Sugen5416/hypoxia/normoxia-exposed pulmonary arterial hypertensive rats.

Authors:  Michie Toba; Abdallah Alzoubi; Kealan D O'Neill; Salina Gairhe; Yuri Matsumoto; Kaori Oshima; Kohtaro Abe; Masahiko Oka; Ivan F McMurtry
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-15       Impact factor: 4.733

9.  Spontaneous pulmonary hypertension in genetic mouse models of natural killer cell deficiency.

Authors:  Matthew T Rätsep; Stephen D Moore; Salema Jafri; Melissa Mitchell; Hugh J M Brady; Ofer Mandelboim; Mark Southwood; Nicholas W Morrell; Francesco Colucci; Mark L Ormiston
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-09-20       Impact factor: 5.464

10.  Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure.

Authors:  Colin M Suen; Ketul R Chaudhary; Yupu Deng; Baohua Jiang; Duncan J Stewart
Journal:  Cardiovasc Res       Date:  2019-03-15       Impact factor: 10.787
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.